Vytorin Information
What's inside Vytorin
Vytorin Active Ingredients: simvastatin, ezetimibe, details.| Vytorin Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Vytorin 10 mg-40 mg | tablet | oral | 1.0 each | OTC |
| Vytorin 10 mg-10 mg | tablet | oral | 1.0 each | OTC |
| Vytorin 10 mg-20 mg | tablet | oral | 1.0 each | OTC |
| Vytorin 10 mg-80 mg | tablet | oral | 1.0 each | OTC |
Recent Vytorin Side Effects
Posted by paranorth about 1 month ago
On Vytorin for the first time 10/80 for 8 weeks -cholesterol numbers are fine now. My liver count was slightly high and my d...
Posted by laker about 1 month ago
* Completely sunburned after 30 minutes in the sun
* Have to get up at least once a night to urinate (never had before)
*...
Posted by nilram97 about 1 month ago
Yes, I have been taking Vytorin 10/40 for about 10 months, and it did reduce my cholesterol and triglycerides to 'normal', ho...
Vytorin in the News
Concerns over Vytorin, Avandia prompt investigation of FDA review - WOI
The Government Accountability Office wants to know if GlaxoSmithKline's diabetes pill Avandia and the cholesterol drug Vytorin -- made by the New ...
Tue Mar 04 23:02:35 -0500 2008
FDA faces scrutiny for review process on Avandia, Vytorin - San Francisco Chronicle
Inc. and Schering-Plough's cholesterol drug Vytorin. The Iowa Republican requested the investigation after recent studies suggested the drugs may not lower ...
Wed Mar 05 08:57:53 -0500 2008
Allure fades for shares of drug makers their shine - International Herald Tribune
The drop came after a study found that their joint cholesterol treatment, Vytorin, formed by blending two other drugs, was not significantly more effective ...
Sat Mar 01 17:14:15 -0500 2008
Vytorin Chemical Information
simvastatin - A lipid-lowering agent derived synthetically from a fermentation product of the fungus Aspergillus terreus. Hydrolyzed in vivo to an active metabolite, simvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)
ezetimibe - An azetidinone derivative and a cholesterol absorption inhibitor with lipid-lowering activity. Ezetimibe appears to interact physically with cholesterol transporters at the brush border of the small intestine and inhibits the intestinal absorption of cholesterol and related phytosterols. As a result, ezetimibe causes a decrease in the level of blood cholesterol or an increase in the clearance of cholesterol from the bloodstream. Overall, the following effects observed are a reduction of hepatic cholesterol stores and a reduction of total cholesterol, LDL cholesterol, and other triglycerides in the blood.
Vytorin RSS Feed